Single Temporary Stimulus Steers Cell Fate Without Altering Genes

Every cell in the human body carries the same genome, yet a heart cell, a neuron, and an immune cell behave in radically different ways because of the intricate web of molecular interactions that decides which genes are active at any given moment. For decades, scientists trying to push cells toward a desired identity have relied on brute-force approaches: locking specific genes permanently into an on or off state and hoping the cell settles into the intended configuration. A research team at the Korea Advanced Institute of Science and Technology, led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering, has now introduced a fundamentally different strategy. Their new framework, called NUDGE, shows that a single, temporary intervention can redirect a cell toward a target state by working with the gene regulatory dynamics the cell already possesses, rather than against them.

The problem with permanent control is well documented in the field. When engineers force a gene to remain continuously active or silenced, the cell may reach the desired phenotype, but it often loses plasticity, the adaptive flexibility that allows cells to respond to future environmental changes. Worse, permanent interventions can generate abnormal equilibrium states that do not exist in natural biology, raising safety concerns for any therapeutic application. Cho’s team set out to answer a deceptively simple question: is it possible to guide a cell to a stable desired state with a minimal, transient push, and then let the cell’s own regulatory machinery hold it there?

NUDGE, which stands for natural dynamics control of gene regulatory networks, approaches this question through computational logic modeling. The framework builds a model of how key genes inside a cell influence one another and uses that model to determine which stable state, or attractor, the cell will ultimately settle into. It then mathematically decomposes the logical functions describing these gene interactions to identify the minimal combination of control factors required to convert a cell from its current state to the desired one. In practical terms, if the goal is to differentiate a stem cell into a cardiomyocyte, NUDGE functions as a blueprint for minimal intervention, specifying exactly which molecular targets need to be briefly activated or inhibited and for how long.

One of the most striking features of the framework is its mathematical rigor. The exact version of NUDGE comes with a formal guarantee: it identifies all minimal control combinations that lead to the desired phenotype within the model. Because exhaustive search becomes intractable for large molecular networks, the team also developed an efficient approximation method that extends the approach to systems with hundreds or thousands of interacting components. This combination of exactness at small scale and scalability at large size positions NUDGE as a general-purpose tool rather than a bespoke solution for a single cell type.

The performance numbers reported in the study are substantial. When the researchers assessed permanent control across 63 published biological network models in which fixing a single node was sufficient to achieve the target phenotype, 55 of those models showed reduced plasticity or attractors absent from the uncontrolled network, confirming the limitations of conventional approaches. Separately, NUDGE’s approximation method achieved an average intervention error below 0.01 in more than 90 percent of 552 control problems spanning 69 large biological networks. Error in this context measured the fraction of simulated converged states that displayed the undesired phenotype. Among minimum-sized, error-free interventions pooled from three competing methods for each problem, NUDGE found an average of 83 percent, compared with 59 percent for IBMFA and 53 percent for LDOI, two established control-theory baselines.

Beyond identifying which factors to stimulate, NUDGE offers something rare among control frameworks: a window into the trajectory itself. The method can analyze which pathways a stimulated cell follows as it transitions toward the target state and how stably that state is maintained once reached. This means researchers can anticipate, before running a single experiment, whether unexpected or pathological states might emerge along the way. For therapeutic applications, where an off-target cell state could mean disease rather than repair, this predictive capability could prove as valuable as the control strategy itself.

To test whether the framework explains real biology rather than merely manipulating abstract models, the team applied NUDGE to three distinct processes. In cardiomyocyte differentiation, the framework reproduced the known pattern in which MESP1, a gene critical for heart development and regeneration, is briefly active early in differentiation but silent in mature cardiomyocytes. The model demonstrated how a single temporary intervention involving MESP1 and one additional regulatory target can guide differentiation without keeping MESP1 continuously active, mirroring what nature itself appears to do.

The second and third applications extended the framework into immunology. In modeling mast cell formation, the cells responsible for allergic responses, NUDGE identified GATA2 and GATA1 as key regulators of cell fate during differentiation. In the macrophage model, the team derived optimal strategies for a single temporary intervention, including one using the signaling molecule IL-4, to induce anti-inflammatory M2 states. Crucially, the intervention preserved the cell’s capacity to transition between inflammatory and anti-inflammatory phenotypes and among M2 subtypes, exactly the kind of retained plasticity that permanent gene locking destroys.

The significance of this work lies in its generality. NUDGE provides a framework that identifies where a single temporary intervention can guide a cell to a desired state, provided a stable state with the desired phenotype exists in the network’s uncontrolled dynamics. The anticipated applications are broad: steering stem cells into specific lineages such as cardiomyocytes, normalizing diseased or aged cells, regenerating damaged tissue, modulating immune responses in autoimmune disease, and designing cancer reversion therapies that return malignant cells to a near-normal state rather than killing them outright. Professor Cho emphasized that NUDGE is not limited to returning a specific cell to a healthy state but constitutes a general-purpose cell-control technology that guides a cell from its current state to a desired state through a single minimal stimulus, with potential as a foundational tool across stem cell biology, aging research, regenerative medicine, and oncology.

The study, conducted by co-first authors Ferio Brahmana and Corbin Hopper, with Woojeong Lee as co-author, all of KAIST’s Department of Bio and Brain Engineering, was published online on September 14 in the Proceedings of the National Academy of Sciences under the title Uncovering minimal control of cell fate by natural dynamics. The work was supported by National Research Foundation of Korea grants funded by the Korean government, the Ministry of Science and ICT, the Korea Dementia Research Project, and internal KAIST convergence research programs. If its predictions hold up in experimental and clinical settings, the idea that a brief nudge, rather than a permanent rewrite, is enough to redirect a cell’s destiny could reshape how regenerative medicine is practiced, moving the field from forced reprogramming toward something closer to a conversation with the cell’s own dynamics.

Subject of Research: Computational control of cell fate through minimal temporary intervention in gene regulatory networks

Article Title: KAIST finds a way to redirect cell fate with just a single stimulus

Article References: KAIST finds a way to redirect cell fate with just a single stimulus. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: cell fate control, gene regulatory networks, NUDGE, KAIST, stem cell differentiation, cardiomyocytes, macrophages, regenerative medicine, cancer reversion, systems biology, attractor control, PNAS